Status: Recruiting
Pre-treatment With Azithromycin to Reduce Immunogenicity to to Anti-TNF Agents in Patients With Crohn's Disease
This is a randomized placebo-controlled trial in Crohn's disease patients before initiation of anti-tumor necrosis factor-α (anti-TNF) therapy that aims to test the effect of a pre-treatment short course of azithromycin therapy on immunogenicity
Participants needed: 180
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Rambam Health Care CampusUpdated: Apr 4, 2025Locations: 9
Eligibility criteria
Ability to provide written informed consent prior to any study procedures and wi... [+4]
Inclusion in another interventional study [+16]